Department of Transplant, Mayo Clinic Florida, Jacksonville, Florida, USA.
Department of Transplant, Mayo Clinic Florida, Jacksonville, Florida, USA,
Kidney Blood Press Res. 2024;49(1):397-405. doi: 10.1159/000539012. Epub 2024 May 24.
The scarcity of available organs for kidney transplantation has resulted in a substantial waiting time for patients with end-stage kidney disease. This prolonged wait contributes to an increased risk of cardiovascular mortality. Calcification of large arteries is a high-risk factor in the development of cardiovascular diseases, and it is common among candidates for kidney transplant. The aim of this study was to correlate abdominal arterial calcification (AAC) score value with mortality on the waitlist.
We modified the coronary calcium score and used it to quantitate the AAC. We conducted a retrospective clinical study of all adult patients who were listed for kidney transplant, between 2005 and 2015, and had abdominal computed tomography scan. Patients were divided into two groups: those who died on the waiting list group and those who survived on the waiting list group.
Each 1,000 increase in the AAC score value of the sum score of the abdominal aorta, bilateral common iliac, bilateral external iliac, and bilateral internal iliac was associated with increased risk of death (HR 1.034, 95% CI: 1.013, 1.055) (p = 0.001). This association remained significant even after adjusting for various patient characteristics, including age, tobacco use, diabetes, coronary artery disease, and dialysis status.
The study highlights the potential value of the AAC score as a noninvasive imaging biomarker for kidney transplant waitlist patients. Incorporating the AAC scoring system into routine imaging reports could facilitate improved risk assessment and personalized care for kidney transplant candidates.
可供肾移植使用的器官稀缺,导致终末期肾病患者等待时间延长。这种长时间的等待增加了心血管死亡率的风险。大动脉钙化是心血管疾病发展的高危因素,在肾移植候选人群中很常见。本研究旨在探讨腹主动脉钙化(AAC)评分值与等待名单上死亡率之间的相关性。
我们修改了冠状动脉钙评分,并使用它来定量 AAC。我们对 2005 年至 2015 年间接受过腹部计算机断层扫描的所有成年肾移植候选患者进行了回顾性临床研究。患者分为两组:等待名单上死亡组和等待名单上存活组。
腹主动脉、双侧髂总动脉、双侧髂外动脉和双侧髂内动脉总和的 AAC 评分值每增加 1000,死亡风险增加(HR 1.034,95%CI:1.013,1.055)(p = 0.001)。即使在调整了年龄、吸烟、糖尿病、冠心病和透析状态等各种患者特征后,这种相关性仍然显著。
本研究强调了 AAC 评分作为肾移植等待名单患者的非侵入性成像生物标志物的潜在价值。将 AAC 评分系统纳入常规成像报告中,可以促进对肾移植候选者的风险评估和个性化护理。